• Viewed 10,240 times by 3014 users (Last 30 days)
  • print Created with Sketch. Print
OIL 7.14% 10.5¢

OPTISCAN IMAGING LIMITED

Optiscan Imaging Limited is an Australia-based company, which is engaged in the... Optiscan Imaging Limited is an Australia-based company, which is engaged in the development, manufacturing and commercialization of confocal endomicroscopic imaging technologies for medical, translational and pre-clinical applications. The Company’s technology enables real-time, non-destructive, three-dimensional (3D), in-vivo imaging at the single-cell level. It provides real-time microscopic imaging tools to healthcare providers and researchers to enable the early detection and management of disease. Its InVivage device is developed for clinical use in oral cancer and other cancer applications. Its Fluorescence In Vivo Endomicroscopy (FIVE2) also known as ViewnVivo system, is a hand-held, confocal microscope designed for pre-clinical use. This device is targeted for use by universities and medical research institutions to explore potential applications of the technology through laboratory testing of tissue samples.More

Corporate Spotlight
Not Yet Available

Are you a Company Director ?
Put your Investment Case to Hotcopper's 700K monthly unique visitors.

Latest Threads

Tag Subject Date Created with Sketch. Comments Created with Sketch. Views Created with Sketch.
OIL
Good signs ....
2 3 4
16/04/24 225 84K
16/04/24 Last post  Klimashkinov Comments Created with Sketch.  225  Views Created with Sketch.  84K 
OIL
Optiscan Improving Cancer Outcomes with Digital Pathology & Precision Surgery
12/04/24 8 10K
12/04/24 Last post  dory Comments Created with Sketch.  8  Views Created with Sketch.  10K 
OIL 02/04/24 3 1.6K
02/04/24 Last post  jsonm Comments Created with Sketch.  3  Views Created with Sketch.  1.6K 
OIL
Tiresias, wherefore art thou Tiresias
28/03/24 2 1.4K
28/03/24 Last post  chand Comments Created with Sketch.  2  Views Created with Sketch.  1.4K 
OIL 20/03/24 0 232
20/03/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  232 
OIL 23/02/24 0 1.1K
23/02/24 Last post  ASX News Comments Created with Sketch.  0  Views Created with Sketch.  1.1K 
OIL 15/02/24 14 4.8K
15/02/24 Last post  grussellt Comments Created with Sketch.  14  Views Created with Sketch.  4.8K 
OIL
FDA: Oral De Novo
07/02/24 9 3.4K
07/02/24 Last post  dory Comments Created with Sketch.  9  Views Created with Sketch.  3.4K 

See All Discussions arrow Created with Sketch.

Timeline

Optiscan appoints US Clinical & Regulatory Heads
02 Apr 12:10
 
Optiscan receives R&D Tax Incentive Rebate
20 Mar 09:38
 
OIL Appendix 4D and 31 December 2023 Half-year report
23 Feb 09:49
 
Optiscan receives $3 million CRC-P Industry Grant
13 Feb 12:28
 
OIL December 2023 Quarterly Report and Appendix 4C
31 Jan 08:28
 
Release of securities from escrow
13 Dec 19:41
 
View More arrow Created with Sketch.
(20min delay)
Last
10.5¢
Change
0.007(7.14%)
Mkt cap ! $87.71M
Open High Low Value Volume
9.8¢ 11.0¢ 9.8¢ $97.91K 934.6K

Buyers (Bids)

No. Vol. Price($)
1 25000 9.8¢
 

Sellers (Offers)

Price($) Vol. No.
10.5¢ 6180 1
View Market Depth
Last trade - 16.10pm 16/04/2024 (20 minute delay) ?
Last
10.0¢
  Change
0.007 ( 2.04 %)
Open High Low Volume
9.8¢ 10.5¢ 9.8¢ 125058
Last updated 15.44pm 16/04/2024 ?
OIL (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.